It is not a GLP-1 agonist drug, nor is it intended to replace GLP-1 agonist drugs
Because cholesterol and triglyceride levels are tied closely to weight, metabolism, and how your body manages fats, medications like GLP-1 may have side benefits beyond just weight or glucose control
Epidemiology of endometriosis
Yang Q, Zhou F, Tang X et al (2022) Peptide-based long-acting co-agonists of GLP-1 and cholecystokinin 1 receptors as novel anti-diabesity agents
Signal transduction in astrocytes during chronic or acute treatment with drugs (SSRIs, antibipolar drugs, GABA-ergic drugs, and benzodiazepines) ameliorating mood disorders
Side effects included gastrointestinal disorders (including nausea and vomiting), which affected 10% of people who used Wegovy compared to 2 percent of people who used the placebo